Diabetes management in disadvantaged communities improves significantly with financial incentives, study finds
Peer-Reviewed Publication
Updates every hour. Last Updated: 28-May-2026 13:15 ET (28-May-2026 17:15 GMT/UTC)
A new study examined whether providing financial vouchers to offset medication costs, conditional on improved blood sugar levels, could enhance glycemic control. The results demonstrated that participants receiving these performance-based incentives achieved a significantly larger reduction in HbA1c levels compared to a control group, an improvement clinically comparable to adding a new pharmacological treatment. Based on these findings, the authors conclude that incorporating financial incentives into health insurance plans could serve as an effective, optional tool to improve health outcomes and equity for low-income populations.
A new analysis led by UC Berkeley, published today in JAMA Health Forum, shows that the passage of "red flag" laws — also called extreme risk protection orders — does reduce suicides by gun. The researchers looked at data from four states that passed ERPO laws and eight that did not, and concluded that the laws reduced firearm suicides by a mean of 3.79 incidences per 100,000 population, with an estimated 675 suicides prevented across these four states between the year the law was passed and following year. Non-firearm suicide rates did not change.
Long-term research and new policy frameworks needed / Practical barriers must be overcome / Six concrete areas for action identified
Many promising drug molecules fail to reach patients because they do not dissolve well enough in water, limiting their effectiveness when taken orally. Now, researchers from Japan investigated an innovative method that uses sublimation to load drugs into a mesoporous silica carrier without relying on organic solvents. Using ibuprofen as a model compound, they showed that this approach can produce formulations with significantly enhanced solubility, offering a cleaner and more sustainable strategy for drug development.